107 related articles for article (PubMed ID: 35367109)
1. Preoperative comprehensive malignancy risk estimation for thyroid nodules: Development and verification of a network-based prediction model.
Shao G; Sun B; Shi M; Song Y; Sun Z; Hao X; Li L; Fu Z
Eur J Surg Oncol; 2022 Jun; 48(6):1264-1271. PubMed ID: 35367109
[TBL] [Abstract][Full Text] [Related]
2. Web-Based Malignancy Risk Estimation for Thyroid Nodules Using Ultrasonography Characteristics: Development and Validation of a Predictive Model.
Choi YJ; Baek JH; Baek SH; Shim WH; Lee KD; Lee HS; Shong YK; Ha EJ; Lee JH
Thyroid; 2015 Dec; 25(12):1306-12. PubMed ID: 26437963
[TBL] [Abstract][Full Text] [Related]
3. Does a higher American College of Radiology Thyroid Imaging Reporting and Data System (ACR TI-RADS) score forecast an increased risk of malignancy? A correlation study of ACR TI-RADS with FNA cytology in the evaluation of thyroid nodules.
Modi L; Sun W; Shafizadeh N; Negron R; Yee-Chang M; Zhou F; Simsir A; Sheth S; Brandler TC
Cancer Cytopathol; 2020 Jul; 128(7):470-481. PubMed ID: 32078249
[TBL] [Abstract][Full Text] [Related]
4. ACR TI-RADS and ATA US scores are helpful for the management of thyroid nodules with indeterminate cytology.
Barbosa TLM; Junior COM; Graf H; Cavalvanti T; Trippia MA; da Silveira Ugino RT; de Oliveira GL; Granella VH; de Carvalho GA
BMC Endocr Disord; 2019 Oct; 19(1):112. PubMed ID: 31664992
[TBL] [Abstract][Full Text] [Related]
5. Accuracy of the 'CUT' Score for Assessing Malignancy in Bethesda 3 and 4 Thyroid Nodules in North American Population: A Retrospective Study.
Shihabi AN; Hussein M; Toraih EA; Attia AS; Youssef MR; Elnahla A; Omar M; Shama M; Corsetti R; Kandil E
Cancer Invest; 2022 Sep; 40(8):693-699. PubMed ID: 35549502
[TBL] [Abstract][Full Text] [Related]
6. Cancer risk estimation using American College of Radiology Thyroid Imaging Reporting and Data System for cytologically indeterminate thyroid nodules.
Dickey MV; Nguyen A; Wiseman SM
Am J Surg; 2022 Aug; 224(2):653-656. PubMed ID: 35272850
[TBL] [Abstract][Full Text] [Related]
7. Validation of Three Scoring Risk-Stratification Models for Thyroid Nodules.
Ha SM; Ahn HS; Baek JH; Ahn HY; Chung YJ; Cho BY; Park SB
Thyroid; 2017 Dec; 27(12):1550-1557. PubMed ID: 29108488
[TBL] [Abstract][Full Text] [Related]
8. Multitask network for thyroid nodule diagnosis based on TI-RADS.
Han X; Chang L; Song K; Cheng L; Li M; Wei X
Med Phys; 2022 Aug; 49(8):5064-5080. PubMed ID: 35608232
[TBL] [Abstract][Full Text] [Related]
9. Discriminating Malignancy in Thyroid Nodules: The Nomogram Versus the Kwak and ACR TI-RADS.
Xiao J; Xiao Q; Cong W; Li T; Ding S; Shao C; Zhang Y; Liu J; Wu M; Jia H
Otolaryngol Head Neck Surg; 2020 Dec; 163(6):1156-1165. PubMed ID: 32689870
[TBL] [Abstract][Full Text] [Related]
10.
Zhu Y; Wu H; Huang B; Shen X; Cai G; Gu X
Gland Surg; 2020 Oct; 9(5):1674-1684. PubMed ID: 33224845
[TBL] [Abstract][Full Text] [Related]
11. Shear wave elastography combined with the thyroid imaging reporting and data system for malignancy risk stratification in thyroid nodules.
Liu Z; Jing H; Han X; Shao H; Sun YX; Wang QC; Cheng W
Oncotarget; 2017 Jun; 8(26):43406-43416. PubMed ID: 28160573
[TBL] [Abstract][Full Text] [Related]
12. Tumor Growth Rate Does Not Predict Malignancy in Surgically Resected Thyroid Nodules Classified as Bethesda Category III with Architectural Atypia.
Kim M; Jeon MJ; Han M; Lee JH; Song DE; Baek JH; Kim TY; Kim WB; Shong YK; Kim WG
Thyroid; 2019 Feb; 29(2):216-221. PubMed ID: 30421654
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic performance of simplified TI-RADS for malignant thyroid nodules: comparison with 2017 ACR-TI-RADS and 2020 C-TI-RADS.
Chen Z; Du Y; Cheng L; Zhang Y; Zheng S; Li R; Zhang W; Zhang W; He W
Cancer Imaging; 2022 Aug; 22(1):41. PubMed ID: 35978376
[TBL] [Abstract][Full Text] [Related]
14. Thyroid Nodule Management: Thyroid-Stimulating Hormone, Ultrasound, and Cytological Classification System for Predicting Malignancy.
Al Dawish MA; Alwin Robert A; Thabet MA; Braham R
Cancer Inform; 2018; 17():1176935118765132. PubMed ID: 29581701
[TBL] [Abstract][Full Text] [Related]
15. Improving Malignancy Prediction in AUS/FLUS Pediatric Thyroid Nodules with the Aid of Ultrasound.
Arora S; Khoury J; Trout AT; Chuang J
Horm Res Paediatr; 2020; 93(4):239-244. PubMed ID: 32894855
[TBL] [Abstract][Full Text] [Related]
16. A Single-Center Retrospective Validation Study of the American College of Radiology Thyroid Imaging Reporting and Data System.
Zheng Y; Xu S; Kang H; Zhan W
Ultrasound Q; 2018 Jun; 34(2):77-83. PubMed ID: 29596298
[TBL] [Abstract][Full Text] [Related]
17. Malignancy rate in thyroid nodules classified as Bethesda category III (AUS/FLUS).
Ho AS; Sarti EE; Jain KS; Wang H; Nixon IJ; Shaha AR; Shah JP; Kraus DH; Ghossein R; Fish SA; Wong RJ; Lin O; Morris LG
Thyroid; 2014 May; 24(5):832-9. PubMed ID: 24341462
[TBL] [Abstract][Full Text] [Related]
18. Use of Predictive Modeling to Tailor Molecular Testing Utilization for Thyroid Nodules.
Ahmed ST; Fernandes S; Gao Q; Ow TJ; Smith RV; Schiff BA; Mehta V
Otolaryngol Head Neck Surg; 2021 Sep; 165(3):406-413. PubMed ID: 33781120
[TBL] [Abstract][Full Text] [Related]
19. Development of a clinical decision model for thyroid nodules.
Stojadinovic A; Peoples GE; Libutti SK; Henry LR; Eberhardt J; Howard RS; Gur D; Elster EA; Nissan A
BMC Surg; 2009 Aug; 9():12. PubMed ID: 19664278
[TBL] [Abstract][Full Text] [Related]
20. Comparison of diagnostic value of SWE, FNA and BRAF gene detection in ACR TI-RADS 4 and 5 thyroid nodules.
Zhang WB; Deng WF; Mao L; He BL; Liu H; Chen J; Liu Y; Qi TY
Clin Hemorheol Microcirc; 2022; 81(1):13-21. PubMed ID: 35068450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
